2025
SJR Q1
4 matched articles
Journal detail
Cancer Drug Resistance
- Publisher
- OAE Publishing Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
2578532X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,775
- Quartile Q1
- H-Index 36
- Cites/doc 6,92
- Docs (3y) 179
- Cites (3y) 1.184
Clarivate
Web of Science · JCR
No JCR match
Subject classification
Categories (SJR)
- Cancer Research Q1
- Pharmacology (medical) Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | — | 1,775 | — | — | — | — | 36 |
| 2024 | Q1 | — | 1,495 | — | — | — | — | 30 |
| 2023 | Q1 | — | 1,035 | — | — | — | — | 30 |
| 2022 | Q2 | — | 0,815 | — | — | — | — | 30 |
| 2021 | Q2 | — | 0,611 | — | — | — | — | 30 |
| 2020 | — | — | — | — | — | — | — | 30 |
| 2019 | — | — | — | — | — | — | — | 30 |